Blaj, S. and Piso, P. (2018) “Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?”, Current Issues in Pharmacy and Medical Sciences, 30(4), pp. 207–210. doi:10.1515/cipms-2017-0040.